{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:25:18Z","timestamp":1793636718595,"version":"4.5.1"},"reference-count":299,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NHLBI funded T32 post-doctoral fellowship to Katyayini Aribindi"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2024,3,3]]},"DOI":"10.1080\/13543784.2024.2315128","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T20:10:32Z","timestamp":1707163832000},"page":"243-277","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":23,"title":["Investigational pharmacological agents for the treatment of ARDS"],"prefix":"10.1080","volume":"33","author":[{"given":"Katyayini","family":"Aribindi","sequence":"first","affiliation":[{"name":"U.C. Davis School of Medicine","place":["Sacramento, USA"]},{"name":"Veterans Affairs North California Health Care System","place":["Mather, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lim","sequence":"additional","affiliation":[{"name":"U.C. Davis School of Medicine","place":["Sacramento, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyan","family":"Lakshminrusimha","sequence":"additional","affiliation":[{"name":"U.C. Davis School of Medicine","place":["Sacramento, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5724-3300","authenticated-orcid":false,"given":"Timothy","family":"Albertson","sequence":"additional","affiliation":[{"name":"U.C. Davis School of Medicine","place":["Sacramento, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(67)90168-7"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0291"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202007-772OC"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.739596"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.05.047"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1608077"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0069-0"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/138.3.720"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.149.3.7509706"},{"issue":"23","key":"e_1_3_4_12_1","first-page":"2526","article-title":"Acute respiratory distress syndrome: the berlin definition","volume":"307","author":"Force ADT","unstructured":"Force ADT, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the berlin definition. JAMA. 2012 Jun 20;307(23):2526\u20132533.","journal-title":"JAMA"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201503-0584OC"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00105-3"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-012-2682-1"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202303-0558WS"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004477.pub3"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02186-4"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2022.10.001"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227664"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012041.pub2"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2018.10.026"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/nicc.12687"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30171-6"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.1995"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200201000-00001"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911124"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02346-0"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1823-x"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31820bd185"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1435"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199908000-00001"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.6812"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.5578\/tt.20219611"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000057843.47705.E8"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0704(18)30589-X"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.3109\/01913129209023751"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.2.9712038"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000057846.21303.AB"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000149854.61192.DC"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.103.3.932"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202008-1026OC"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-2025LE"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015432"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2023.02.003"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06062-x"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004504"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004472"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39537.939039.BE"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.80324"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2014.08.014"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2637"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093340"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17021"},{"issue":"8","key":"e_1_3_4_55_1","first-page":"693","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Group RC","unstructured":"Group RC, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384(8):693\u2013704.","journal-title":"N Engl J Med"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17022"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-022-00993-4"},{"key":"e_1_3_4_58_1","unstructured":"Dexamethasone early administration in hospitalized patients with covid-19 pneumonia and high risk of developing acute respiratory distress syndrome [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2021. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04836780?term=NCT04836780&draw=2&rank=1."},{"key":"e_1_3_4_59_1","unstructured":"A factorial trial of glucocorticoid therapy in acute respiratory distress syndrome: optimizing dosing regimen and developing biomarker-guided treatment [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2022. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/record\/NCT05401812?term=dexamethasone&cond=ARDS%2C+human&draw=2&rank=6."},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002284"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.12479"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2001.v7.pm11400949"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/1099-0496(200010)30:4<275::AID-PPUL1>3.0.CO;2-G"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70204-4"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20467"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01744-X"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00160-0"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068060"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.6759"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02921-2021"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015125"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209421"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138003"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00897-7"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031304"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3939"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01471-2021"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150646"},{"key":"e_1_3_4_79_1","unstructured":"Organization WH WHO R&D blueprint \u2013 COVID-19 therapeutic trial synopsis. 2020 [cited 2024 Jan 5]. Available from: https:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/COVID-19_Treatment_Trial_Design_Master_Protocol_synopsis_Final_18022020.pdf"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10044"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30483-7"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209502"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.061911-0"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22525"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.11825"},{"issue":"23","key":"e_1_3_4_86_1","first-page":"2191","article-title":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome","volume":"370","author":"Truwit JD","unstructured":"National Heart L, Blood Institute ACTN, Truwit JD, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med.2014;370(23):2191\u20132200.","journal-title":"N Engl J Med"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403285"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03451-z"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06570-4"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124039"},{"key":"e_1_3_4_91_1","first-page":"1","article-title":"Effect of sivelestat in the treatment of acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"1","author":"Ding Q","year":"2023","unstructured":"Ding Q, Wang Y, Yang C, et al. Effect of sivelestat in the treatment of acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Intensive Care Res. 2023;1:1\u201310.","journal-title":"Intensive Care Res"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000133332.48386.85"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2011.03.001"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-2234-7"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70259-5"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00300.2011"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3182120cb8"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu5083131"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050312118807615"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-20-1306"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2021.100891"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2023.2240020"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1159\/000442794"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2016-0236RC"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.3109\/01902140903131200"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133453"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2008.00041.x"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2021.PA734"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.270"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1243-8"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2748"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06367-5"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14015"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932251"},{"key":"e_1_3_4_115_1","unstructured":"Add-on reparixin in adult patients with ARDS [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2022 [cited 2023 Oct 5]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05496868?term=NCT05496868&draw=2&rank=1."},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01583"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44231-022-00012-5"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000129996.22368.85"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ta.0000217271.25809.a0"},{"issue":"84","key":"e_1_3_4_120_1","first-page":"967","article-title":"Usefulness of a selective neutrophil elastase inhibitor (sivelestat) in septic ARDS patients after gastrointestinal surgery","volume":"55","author":"Togo S","year":"2008","unstructured":"Togo S, Matsuo K, Ishibe A, et al. Usefulness of a selective neutrophil elastase inhibitor (sivelestat) in septic ARDS patients after gastrointestinal surgery. Hepatogastroenterology. 2008;55(84):967\u2013973.","journal-title":"Hepatogastroenterology"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2008.01283.x"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e3181aa95c4"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S42004"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-014-0067-y"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.21037\/tp-22-441"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70111-1"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-005-2859-y"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00354.2004"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200810-1584OC"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12820"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2016.06.010"},{"issue":"1","key":"e_1_3_4_132_1","first-page":"51","article-title":"Statin in the treatment of ALI\/ARDS: a systematic review and meta-analysis based on international databases","volume":"29","author":"Chen M","year":"2017","unstructured":"Chen M, Lu J, Chen Q, et al. Statin in the treatment of ALI\/ARDS: a systematic review and meta-analysis based on international databases. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017;29(1):51\u201356.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201805_15080"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04387-9"},{"key":"e_1_3_4_135_1","unstructured":"Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome (PETARDS) [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2022."},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-0968-6"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22341-7"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.5492\/wjccm.v3.i1.34"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05588-9"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1795-x"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.09.021"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06182-3"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00093"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059040-00010"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14621"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(95)02051-9"},{"key":"e_1_3_4_147_1","unstructured":"Influence of NEP inhibition on vascular leak and inflammation (NEPi-INFLAMMATION) [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2023 [cited 2023 Sep 14]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05600062?term=nct05600062&draw=2&rank=1."},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-06-0400"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi094"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-12-5"},{"key":"e_1_3_4_151_1","unstructured":"Effects of TNX-832 (Sunol cH36) in Subjects with Acute Lung Injury\/Acute Respiratory Distress Syndrome [Internet]. NIH > U.S. National Library of Medicine. 2011 [cited 2011 Sep 22]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT01438853?term=nct01438853&draw=2&rank=1."},{"key":"e_1_3_4_152_1","unstructured":"Anti-TF antibody (ALT-836) to treat septic patients with acute lung injury or acute respiratory distress syndrome [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2009 [cited 2015 Apr 10]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT00879606?term=nct00879606&draw=2&rank=1."},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181733115"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00240.2015"},{"key":"e_1_3_4_155_1","unstructured":"Safety study of inhaled carbon monoxide to treat acute respiratory distress syndrome (ARDS) [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2015 [cited 2019 Oct 17]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02425579?term=nct02425579&draw=2&rank=1."},{"key":"e_1_3_4_156_1","unstructured":"Safety and efficacy study of inhaled carbon monoxide to treat acute respiratory distress syndrome (ARDS) [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2019 [cited 2022 Aug 23]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03799874?term=nct03799874&draw=2&rank=1."},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2551"},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.17-0129"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181f1ff1d"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1159\/000347072"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-15-39"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2015-0021"},{"key":"e_1_3_4_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70291-7"},{"key":"e_1_3_4_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30418-1"},{"key":"e_1_3_4_165_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004285"},{"key":"e_1_3_4_166_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.148983"},{"key":"e_1_3_4_167_1","unstructured":"Mesenchymal stem cells (MSCs) for treatment of acute respiratory distress syndrome (ARD) in patients with malignancies [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2016 [cited 2020 Apr 10]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02804945?term=nct02804945&draw=2&rank=1"},{"key":"e_1_3_4_168_1","unstructured":"Bone marrow mesenchymal stem cell derived extracellular vesicles infusion treatment for ARDS (EXIT-ARDS) [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2021 [cited 2023 May 6]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05127122?term=NCT05127122&draw=2&rank=1"},{"key":"e_1_3_4_169_1","unstructured":"Extracellular vesicle treatment for acute respiratory distress syndrome (ARDS) (EXTINGUISH ARDS) [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2022 [cited 2023 Oct 17]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05354141?term=nct05354141&draw=2&rank=1"},{"key":"e_1_3_4_170_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02536-2020"},{"key":"e_1_3_4_171_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.916159"},{"key":"e_1_3_4_172_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04444-9"},{"key":"e_1_3_4_173_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14121322"},{"key":"e_1_3_4_174_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2021-0357OC"},{"key":"e_1_3_4_175_1","unstructured":"First-in-human study to investigate the safety tolerability pharmacokinetics and pharmacodynamics of ALT-100 [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2022 [cited 2023 Sep 14]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05426746?term=NCT05426746&draw=2&rank=1"},{"key":"e_1_3_4_176_1","unstructured":"Study of safety and efficacy of ALT-100mAb in participants with moderate\/severe ARDS [Internet]. ClinicalTrials.gov: NIH > U.S. National Library of Medicine. 2023 [cited 2023 Jul 10]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05938036?term=NCT05938036&draw=2&rank=1"},{"key":"e_1_3_4_177_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11779"},{"issue":"18","key":"e_1_3_4_178_1","first-page":"1745","article-title":"Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials","volume":"330","author":"Adhikari NKJ","unstructured":"Lovit-Covid Investigators obotCCCTG, the R-CAPI, Adhikari NKJ, et al. Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials. JAMA. 2023: 330(18):1745\u20131759.","journal-title":"JAMA"},{"key":"e_1_3_4_179_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00792-3"},{"key":"e_1_3_4_180_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05795-4"},{"issue":"4","key":"e_1_3_4_181_1","first-page":"1559","article-title":"A multicenter phase 2 randomized controlled study on the efficacy and safety of reparixin in the treatment of hospitalized patients with COVID-19 pneumonia","volume":"11","author":"Landoni G","year":"2022","unstructured":"Landoni G, Piemonti L, Monforte AD, et al. A multicenter phase 2 randomized controlled study on the efficacy and safety of reparixin in the treatment of hospitalized patients with COVID-19 pneumonia. Infect Dis Ther. 2022;11(4):1559\u20131574.","journal-title":"Infect Dis Ther"},{"key":"e_1_3_4_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00331-3"},{"key":"e_1_3_4_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00006-6"},{"key":"e_1_3_4_184_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.019"},{"key":"e_1_3_4_185_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101643"},{"key":"e_1_3_4_186_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005682"},{"key":"e_1_3_4_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01109-6"},{"key":"e_1_3_4_188_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031994"},{"key":"e_1_3_4_189_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202201-0157OC"},{"key":"e_1_3_4_190_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202302-0297OC"},{"key":"e_1_3_4_191_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-03930-4"},{"key":"e_1_3_4_192_1","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0472"},{"key":"e_1_3_4_193_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03402-8"},{"key":"e_1_3_4_194_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01815-18"},{"key":"e_1_3_4_195_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.615398"},{"key":"e_1_3_4_196_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2022.03.001"},{"key":"e_1_3_4_197_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21085-8"},{"key":"e_1_3_4_198_1","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usac362"},{"key":"e_1_3_4_199_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1798399"},{"key":"e_1_3_4_200_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1905794"},{"key":"e_1_3_4_201_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01870-2021"},{"key":"e_1_3_4_202_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00494-X"},{"key":"e_1_3_4_203_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30170-3"},{"key":"e_1_3_4_204_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1859OC"},{"key":"e_1_3_4_205_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00460-4"},{"key":"e_1_3_4_206_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153173"},{"key":"e_1_3_4_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106903"},{"key":"e_1_3_4_208_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30511-7"},{"key":"e_1_3_4_209_1","first-page":"e068407","article-title":"Atorvastatin versus placebo in patients with COVID-19 in intensive care: randomized controlled trial","volume":"376","author":"Investigators I-S","unstructured":"Investigators I-S. Atorvastatin versus placebo in patients with COVID-19 in intensive care: randomized controlled trial. BMJ. 2022;376:e068407.","journal-title":"BMJ"},{"key":"e_1_3_4_210_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103417"},{"key":"e_1_3_4_211_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.4152"},{"key":"e_1_3_4_212_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.09.024"},{"key":"e_1_3_4_213_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2021.12.003"},{"key":"e_1_3_4_214_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2400"},{"key":"e_1_3_4_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00298-3"},{"key":"e_1_3_4_216_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000134595.80170.62"},{"key":"e_1_3_4_217_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03690-7"},{"issue":"9","key":"e_1_3_4_218_1","first-page":"4269","article-title":"The effect of using iloprost on prognosis in COVID-19 patients with ARDS: a retrospective clinical study","volume":"27","author":"Sari Kucuk R","year":"2023","unstructured":"Sari Kucuk R, Uluc K, Merve Colakoglu S, et al. The effect of using iloprost on prognosis in COVID-19 patients with ARDS: a retrospective clinical study. Eur Rev Med Pharmacol Sci. 2023;27(9):4269\u20134279.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_4_219_1","doi-asserted-by":"publisher","DOI":"10.1177\/08850666221086521"},{"key":"e_1_3_4_220_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-023-01150-9"},{"key":"e_1_3_4_221_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2023184"},{"key":"e_1_3_4_222_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32013-4"},{"key":"e_1_3_4_223_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"e_1_3_4_224_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2020-137785"},{"issue":"21","key":"e_1_3_4_225_1","first-page":"2030","article-title":"Effect of hydroxychloroquine in hospitalized patients with covid-19","volume":"383","author":"Group RC","unstructured":"Group RC, Horby P, Mafham M, et al. Effect of hydroxychloroquine in hospitalized patients with covid-19. N Engl J Med. 2020;383(21):2030\u20132040.","journal-title":"N Engl J Med"},{"key":"e_1_3_4_226_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00149-5"},{"key":"e_1_3_4_227_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00676-0"},{"key":"e_1_3_4_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101362"},{"key":"e_1_3_4_229_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.6820"},{"key":"e_1_3_4_230_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18764-3"},{"key":"e_1_3_4_231_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201707"},{"key":"e_1_3_4_232_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00435-5"},{"key":"e_1_3_4_233_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.849628"},{"key":"e_1_3_4_234_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01825-0"},{"key":"e_1_3_4_235_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0827"},{"key":"e_1_3_4_236_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00163-5"},{"key":"e_1_3_4_237_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00147-9"},{"key":"e_1_3_4_238_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005660"},{"key":"e_1_3_4_239_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep43395"},{"key":"e_1_3_4_240_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3653"},{"key":"e_1_3_4_241_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"e_1_3_4_242_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"e_1_3_4_243_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.11043"},{"key":"e_1_3_4_244_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-021-00490-1"},{"key":"e_1_3_4_245_1","doi-asserted-by":"publisher","DOI":"10.3390\/life12030453"},{"key":"e_1_3_4_246_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0369"},{"key":"e_1_3_4_247_1","first-page":"164","article-title":"Efficacy of high dose vitamin C, melatonin and zinc in Iranian patients with acute respiratory syndrome due to coronavirus infection: a pilot randomized trial","volume":"6","author":"Darban M","year":"2021","unstructured":"Darban M, Malek F, Memarian M, et al. Efficacy of high dose vitamin C, melatonin and zinc in Iranian patients with acute respiratory syndrome due to coronavirus infection: a pilot randomized trial. J Cell Mol Anesth. 2021;6:164\u2013167.","journal-title":"J Cell Mol Anesth"},{"key":"e_1_3_4_248_1","doi-asserted-by":"publisher","DOI":"10.22037\/uj.v18i.6863"},{"key":"e_1_3_4_249_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.09.023"},{"key":"e_1_3_4_250_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701499"},{"key":"e_1_3_4_251_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2356"},{"key":"e_1_3_4_252_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.12.018"},{"key":"e_1_3_4_253_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2022.10.003"},{"key":"e_1_3_4_254_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5593584"},{"key":"e_1_3_4_255_1","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.21-0046"},{"key":"e_1_3_4_256_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00286-5"},{"key":"e_1_3_4_257_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00488-5"},{"key":"e_1_3_4_258_1","doi-asserted-by":"publisher","DOI":"10.1177\/09636897211024942"},{"key":"e_1_3_4_259_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-02771-w"},{"key":"e_1_3_4_260_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-02796-1"},{"key":"e_1_3_4_261_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-01875-5"},{"key":"e_1_3_4_262_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3005"},{"key":"e_1_3_4_263_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023226"},{"key":"e_1_3_4_264_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17052"},{"key":"e_1_3_4_265_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg9873"},{"key":"e_1_3_4_266_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30308-8"},{"issue":"6","key":"e_1_3_4_267_1","first-page":"606","article-title":"C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 \u2018LIVE-AIR\u2019 trial","volume":"78","author":"Temesgen Z","year":"2023","unstructured":"Temesgen Z, Kelley CF, Cerasoli F, et al. C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 \u2018LIVE-AIR\u2019 trial. Thorax. 2023;78(6):606\u2013616.","journal-title":"Thorax"},{"key":"e_1_3_4_268_1","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-23787"},{"key":"e_1_3_4_269_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2023.2204186"},{"key":"e_1_3_4_270_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131"},{"key":"e_1_3_4_271_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100433"},{"key":"e_1_3_4_272_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa387"},{"key":"e_1_3_4_273_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.019"},{"key":"e_1_3_4_274_1","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00699-20"},{"key":"e_1_3_4_275_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13940-6"},{"key":"e_1_3_4_276_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04864-4"},{"issue":"66","key":"e_1_3_4_277_1","first-page":"RCT2884","article-title":"SPRINTER: a randomized, double-blind, placebo-controlled, phase 3 trial to determine the efficacy and safety of inhaled interferon beta-1a (SNG001) for the treatment of patients hospitalised due to COVID-19 (NCT04732949)","volume":"60","author":"Phillip DM","year":"2022","unstructured":"Phillip DM, Jody B, Victoria T, et al. SPRINTER: a randomized, double-blind, placebo-controlled, phase 3 trial to determine the efficacy and safety of inhaled interferon beta-1a (SNG001) for the treatment of patients hospitalised due to COVID-19 (NCT04732949). Eur Respir J. 2022;60(suppl 66):RCT2884.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_278_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108192"},{"key":"e_1_3_4_279_1","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000001041"},{"key":"e_1_3_4_280_1","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000001441"},{"key":"e_1_3_4_281_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.060785"},{"key":"e_1_3_4_282_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020204"},{"key":"e_1_3_4_283_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108805"},{"key":"e_1_3_4_284_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14890"},{"key":"e_1_3_4_285_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-01027-6"},{"key":"e_1_3_4_286_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10122387"},{"key":"e_1_3_4_287_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29435"},{"key":"e_1_3_4_288_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2023.2153116"},{"key":"e_1_3_4_289_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43644-x"},{"key":"e_1_3_4_290_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2009.04.005"},{"key":"e_1_3_4_291_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30341-6"},{"key":"e_1_3_4_292_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00297-1"},{"key":"e_1_3_4_293_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5378-3"},{"key":"e_1_3_4_294_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12113695"},{"key":"e_1_3_4_295_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201603-0645OC"},{"key":"e_1_3_4_296_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201906-1110RR"},{"key":"e_1_3_4_297_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2023.101426"},{"key":"e_1_3_4_298_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.006"},{"key":"e_1_3_4_299_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2600-6"},{"key":"e_1_3_4_300_1","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. 2024Feb 8. Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/"},{"key":"e_1_3_4_301_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2021.06.017"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2024.2315128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:08:32Z","timestamp":1738202912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2024.2315128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":299,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,3]]}},"alternative-id":["10.1080\/13543784.2024.2315128"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2024.2315128","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}